Evaluate the Effects of Citicoline on Mood in Healthy Adults
Part of paid clinical trials in Canfield, Ohio.
- Sponsor
- Kirin Holdings Company, Limited
- Study ID
- NCT07089238
- Status
- Recruiting
Conditions
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Citicoline — DIETARY_SUPPLEMENTOral
- Placebo — DIETARY_SUPPLEMENTOral
Study Details
The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.
Key Dates
- Start date
- Jul 31, 2025
- Status verified
- Aug 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Citicoline
- Placebo Comparator: Placebo
Primary Outcome Measure
Total Mood Disturbance (TMD) score on the Profile of Mood States second eddition-Adult short (POMS2) [ Time Frame: 4 weeks ]
Central Contacts
- Tim Ziegenfuss, Ph.D., CSCS, FISSN519-341-3367
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Center for Applied Health Sciences | Canfield | Ohio | 44406 |
Find similar trials in Canfield, OH
By research site
Related Studies
- Eccentric Muscle Training, Stimulation, and Biomarkers in SCIRecruiting · Ohio State University · Columbus, Ohio
- Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)Recruiting · The Cleveland Clinic · Cleveland, Ohio
- Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral SuspensionPHASE1 · Not Yet Recruiting · Quivive Pharma, Inc. · Cleveland, Ohio
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).PHASE1 · Recruiting · Merck Sharp & Dohme LLC · Glendale, California